Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The polyamines putrescine, spermidine, and spermine and
ornithine decarboxylase
(
ODC
), the rate-limiting enzyme in their biosynthetic pathway, play an important role in cell proliferation, differentiation, and transformation. In the present study, we have analyzed polyamine concentrations and
ODC
activity in samples from benign breast diseases (n = 36), benign breast tissue adjacent to the primary carcinoma (n = 19), and breast carcinoma (n = 104).
ODC
activity in primary carcinoma was significantly higher (2.42 +/- 0.22 nmol CO2/h g; P < 0.001) than that found in benign breast (0.62 +/- 0.15 nmol CO2/h g) or in breast tissue adjacent to the primary carcinoma (0.52 +/- 0.16 nmol CO2/h g). The total polyamine content of breast cancer tissues was higher than in benign breast diseases (704.3 +/- 38.3 nmol/g wet weight versus 295.8 +/- 27.4 nmol/g wet weight) and correlated well with
ODC
activity (Pearson, r = 0.42; P < 0.001).
ODC
activity correlated with histological grade, peritumoral lymphatic or blood vessel invasion, S-phase fraction, and
cathepsin D
. Total polyamine concentration increased with S-phase fraction,
cathepsin D
, and aneuploidy. No significant correlation was found between
ODC
or polyamines and tumor size, lymph node involvement, or steroid receptor status. A major finding in our study was that
ODC
activity was an independent prognostic factor for recurrence and death. The results indicate that the estimation of
ODC
activity and polyamines in human breast carcinoma might be useful to determine tumor aggressiveness and suggest that
ODC
may have a potential value as both a prognostic factor and a chemoprevention target in human breast cancer.
...
PMID:Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. 1047 83